Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL14966698

CS(=O)(=O)c1ccc(CN2CCN(C3CCNCC3)C2=O)c(F)c1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 8/20 0.43
KCNH2 Q12809 5/20 0.43
TP53 P04637 1/20 0.37
DPP4 P27487 4/20 0.36
DPP7 Q9UHL4 3/20 0.36
RXFP1 Q9HBX9 1/20 0.34
CYP2D6 P10635 2/20 0.34
F2 P00734 2/20 0.34
F10 P00742 2/20 0.34
PRSS1 P07477 2/20 0.34
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16172053 0.92 TP53 (0.42) GPR119KCNH2TP53RXFP1CYP2D6
Trifluoroacetic Acid SCHEMBL16163152 0.88 TP53 (0.37) GPR119KCNH2TP53DPP4DPP7
SCHEMBL14978750 0.88 GPR119 (0.39) GPR119KCNH2TP53RXFP1ALDH1A1
Trifluoroacetic Acid SCHEMBL14966444 0.86 TP53 (0.36) GPR119KCNH2TP53DPP4F2
Trifluoroacetic Acid SCHEMBL16163342 0.85 GPR119 (0.38) GPR119KCNH2DPP4DPP7CYP2D6
Trifluoroacetic Acid SCHEMBL16163282 0.85 GPR119 (0.40) GPR119KCNH2DPP4DPP7CYP2D6
Trifluoroacetic Acid SCHEMBL14970184 0.83 PDE10A (0.38) TP53MEN1ALDH1A1CYP1A2CYP2C9
SCHEMBL14978690 0.81 GPR119 (0.42) GPR119KCNH2TP53RXFP1
SCHEMBL14966130 0.81 GPR119 (0.54) GPR119TP53CYP3A4CYP2C9
SCHEMBL14978753 0.79 TP53 (0.42) GPR119TP53RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140309226-A1 PIPERIDINYL-SUBSTITUTED CYCLIC UREAS AS GPR119 MODULATORS ARRAY BIOPHARMA, INC. 2014-10-16 US disclosed
WO-2013074641-A1 PIPERIDINYL- SUBSTITUTED CYCLIC UREAS AS GPR119 MODULATORS ARRAY BIOPHARMA INC. (US) 2013-05-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140309226-A1 PIPERIDINYL-SUBSTITUTED CYCLIC UREAS AS GPR119 MODULATORS GPR119, UTS2R, GPR139 GPR119 1/4885KCNH2 1308/4885TP53 4454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.